following this weekend's press reports of Astrazeneca/Pfizer talks (AZN LN +6.9% tracking its ADR move yesterday) and news out after the close that Valeant & Pershing Square are teaming up to make a run at Allergan (AGN +21% after the close). And now Novartis & GSK have announced a major series of transactions: creating